Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TechnologyAdvice

- PMLiVE

UK site a casualty as Pfizer reduces pain R&D

Will shut down Granta Park facility in Cambridge with loss of 120 jobs

Daiichi Sankyo logo

Daiichi Sankyo to shut down German antibody unit U3

Will transfer its operations to a research unit in Japan

Sanofi Espoir Foundation appoints new president

Xavier Darcos succeeds Jean-François Dehecq

Eli Lilly HQ

Lilly says insulin peglispro too risky to pursue

Discontinues development of medicine once tipped as a diabetes blockbuster

Face-to-face beats digital as prescribing influence

But report confirms doctors continue to embrace digital technology

- PMLiVE

Blue Latitude’s industry-first praised at PMEA

Support for Lilly and its Medical Information Cascade wins Innovation Award

- PMLiVE

Alexion’s rare bone disorder therapy rejected by NICE

Draft guidance rules Strensiq does not have a compelling enough evidence base

- PMLiVE

GSK’s severe asthma therapy Nucala gets EU nod

Becomes the first IL-5 inhibitor to be approved in the EU

- PMLiVE

Purdue Pharma appoints Dr Alan Dunton

He joins the pain specialist as senior VP of research and development

Lucid team : because you’re worth it!

Lucid group reward the team for an amazing year

Lucid Group Communications Limited

- PMLiVE

Novo Nordisk says Victoza outperforms SGLT2 inhibitors

Comparesthe GLP-1 agonist to Invokana, Jardiance and Farxiga

EISAI

Eisai expands in China with generics company acquisition

BuysLiaoning TianYi Biological Pharmaceutical

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links